Gibbons R P, Correa R J, Brannen G E, Weissman R M
Section of Urology and Renal Transplantation, Virginia Mason Clinic, Seattle, Washington.
J Urol. 1989 Mar;141(3):564-6. doi: 10.1016/s0022-5347(17)40895-0.
The fate of the first 52 patients with clinically localized prostate cancer who underwent total perineal prostatectomy at our clinic and have been followed for a minimum of 15 years is reviewed to evaluate the long-term impact of this operation on the disease. None of these patients received any adjuvant therapy. Nine patients (17 per cent) had recurrence and 5 (10 per cent) died of disease during this interval. The actual observed over-all survival at 15 years was 64 per cent, the actuarial survival was 67 per cent and the cause-specific survival was 90 per cent.
回顾了在我们诊所接受全会阴前列腺切除术且至少随访15年的首批52例临床局限性前列腺癌患者的情况,以评估该手术对疾病的长期影响。这些患者均未接受任何辅助治疗。在此期间,9例患者(17%)复发,5例(10%)死于该疾病。15年时实际观察到的总生存率为64%,精算生存率为67%,病因特异性生存率为90%。